A Study to Evaluate the Ability of a Newly Developed Sperm Antibody to Attach to Human Sperm from Men with Normal Sperm Counts
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 18-002315
Sponsor Protocol Number: 18-002315
About this study
The primary objective of this study is to evaluate the ability of a newly developed sperm antibody to successfully attach to human sperm from men with normal sperm counts.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria
- Males being seen at Mayo Clinic Rochester for suspected male infertility
- >18 years old
Exclusion Criteria
- None
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Landon Trost, M.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available